Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_assertion type Assertion NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_head.
- NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_assertion description "[Similarly, patients with severe congenital neutropenia (SCN) have an increased risk of developing MDS/AML after treatment with rhG-CSF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_provenance.
- NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_assertion evidence source_evidence_literature NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_provenance.
- NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_assertion SIO_000772 11122117 NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_provenance.
- NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_assertion wasDerivedFrom befree-20140225 NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_provenance.
- NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_assertion wasGeneratedBy ECO_0000203 NP239291.RA5qvsdrfH3pBjBm-NWXcNvDiKFLndqJ-yGc2hSsFMAi8130_provenance.